Stockwatch: Drug reimbursement Elysium?
This article was originally published in Scrip
Executive Summary
In the 2013 science fiction film Elysium the human race was divided up into the wealthy, who lived on the utopian space station Elysium with access to the machines that could cure all injuries and diseases, and those who were stuck with poverty and disease back on a dystopian polluted earth. After last week's American College of Cardiology (ACC) conference, we may be a little closer to this sort of bifurcation in healthcare.
You may also be interested in...
Stock Watch: Risk And The Pharmaceutical Discount Rate
In contrast to the SEC’s view that public companies’ regulatory filings give investors all the information needed to make an investment decision, the discount rate used to value a company may not reflect all its risks.
Stock Watch: Pharma Businesses That Leave Consumer Behind
Healthcare conglomerates that divorce consumer, animal health and even generics businesses from their pure-play branded pharmaceutical groups could leave a less diversified and riskier sector in uncertain times. But the advantages are apparent.
Stock Watch: Acadia And Amylyx Trial Failures Were No Shock
The overused phrase ‘pipeline in a product’ translates to ‘disappointment in a product’ when the number of indications in the pipeline contracts towards zero.